Vinblastine and Interferon-Gamma Combination with and without 13-Cis Retinoic Acid for Patients with Advanced Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|63|2|130-138

ISSN： 0030-2414

Source： Oncology, Vol.63, Iss.2, 2002-09, pp. : 130-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study with Interferon alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Carcinoma. A Trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society

By  

Oncology Research and Treatment, Vol. 22, Iss. 5, 1999-11 ,pp. : 412-415

Karger

Access to resources Recommend Favorite

All-Trans Retinoic Acid and Interferon-α for Treatment of Human Renal Cell Carcinoma Multicellular Tumor Spheroids

By  

Urologia Internationalis, Vol. 73, Iss. 1, 2008-06 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Granulocyte-Macrophage Colony-Stimulating Factor and Interferon-Alpha 2B in Patients with Advanced Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 61, Iss. 4, 1999-06 ,pp. : 215-219

Karger

Access to resources Recommend Favorite

An Outpatient Phase II Study of Subcutaneous Interleukin-2 and Interferon-Alpha-2b in Combination with Intravenous Vinblastine in Metastatic Renal Cell Cancer

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 10-15

Karger

Access to resources Recommend Favorite

Temsirolimus in patients with advanced renal cell carcinoma: an overview

By Bhatia Shailender  

Advances in Therapy, Vol. 26, Iss. 1, 2009-01 ,pp. : 55-67

Springer Publishing Company

Access to resources Recommend Favorite